According to a new report Global Liver Disease Diagnostics Market, published by KBV research, The Global Liver Disease Diagnostics Market size is expected to reach $40.7 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period.
The imaging segment dominated the market. This is due to a growing number of steps taken by major players in the liver disease diagnostics industry to improve innovative imaging techniques. Laboratory tests are performed using urine, blood, and other fluid samples to diagnose liver function.
The hospital segment has the highest market share with the bulk of patients depending on well-equipped hospitals with diagnostic testing devices. Hospitals provide optimal treatment to patients and allow early detection and diagnosis, thus boosting the growth of the liver disease diagnostics industry. In addition, the ongoing development of the healthcare infrastructure is expected to enhance existing hospital facilities. The laboratory segment is expected to be the fastest-growing segment of the liver disease diagnostics industry in the forecast years.
North America dominated the market in the regional market. High investment in R&D and the involvement of key players are expected to be responsible for the growth of the liver disease diagnostics market in the region. The market in the Asia Pacific is projected to rise significantly during the forecast period. The growing geriatric population and awareness of regular check-ups are contributing to the growth of the liver disease diagnostics market in this country. Additionally, The Europe market is expected to witness a CAGR of 6.1% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/liver-disease-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited.
By End-User
By Diagnosis Technique
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
